Published ahead of print on September 29, 2005, doi:10.1165/rcmb.2005-0163OC
Am. J. Respir. Cell Mol. Biol., Volume 34, Number 2, February 2006, 182-191
A more recent version of this article appeared on February 1, 2006
Submitted on May 2, 2005
Revised on September 28, 2005
Serotonin-induced Growth of Pulmonary Artery Smooth Muscle Requires Activation of PI3K/Akt/S6K1
Yinglin Liu1 and Barry L Fanburg1*
1 Department of Medicine, Pulmonary, Critical Care and Sleep Division, Tufts-New England Medical Center, Tupper Research Institute, Boston, MA, USA
* To whom correspondence should be addressed. E-mail: bfanburg{at}tufts-nemc.org.
We previously found that both MAPK- and Rho kinase (ROCK)-related signaling pathways are necessary for the induction of pulmonary artery smooth muscle cell (PASMC) proliferation by serotonin (5-HT). Presently we investigated the possible additional participation of a phosphoinositide 3-kinase (PI3K)/Akt/mTOR/p70 ribosomal S6 kinase (S6K1) pathway in this growth response. We found transient activation of Akt (Ser473) and more prolonged activation of S6K1 by 5-HT. Inhibition of PI3K with Wortmannin and LY294002 completely blocked these activations, but not that of MAPK or the Rho kinase substrate myosin phosphatase targeting subunit. Similarly, inhibition of MAPK and ROCK failed to block the Akt activation. Inhibition of Akt with NL-71-101 and downregulation of Akt expression with Akt siRNA blocked 5-HT-induced S6K1 phosphorylation. Wortmannin, LY294002 and NL-71-101 dose dependently inhibited 5-HT-induced SMC proliferation. 5-HT stimulated mTOR phosphorylation and the mTOR inhibitor, rapamycin, blocked activations of S6K1 and S6 ribosomal protein (S6) and inhibited 5-HT-induced SMC proliferation. Akt phosphorylation and cell proliferation were also blocked by the antioxidants, N-acetyl-l-cysteine, Ginko biloba 501 and Tiron; the NADPH oxidase inhibitor, diphenyleneiodonium; and the 5-HT2 receptor antagonist ketanserin and mianserin, but not by the 5-HT transporter (SERT) and 5-HT 1B/1D receptor antagonists. We conclude from these studies that a parallel PI3K- and ROS-dependent Akt/mTOR/S6K1 pathway participates independently from MAPK and Rho/ROCK for the mitogenic effect of 5-HT on PASMCs. From these and other studies we postulate that independent signaling pathways leading to 5-HT-induced SMC proliferation are initiated through multiple 5-HT receptors and SERT at the cell surface.
This article has been cited by other articles:

|
 |

|
 |
 
A. Ogawa, A. L. Firth, W. Yao, M. M. Madani, K. M. Kerr, W. R. Auger, S. W. Jamieson, P. A. Thistlethwaite, and J. X.-J. Yuan
Inhibition of mTOR attenuates store-operated Ca2+ entry in cells from endarterectomized tissues of patients with chronic thromboembolic pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol,
October 1, 2009;
297(4):
L666 - L676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Pena-Silva, J. D. Miller, Y. Chu, and D. D. Heistad
Serotonin produces monoamine oxidase-dependent oxidative stress in human heart valves
Am J Physiol Heart Circ Physiol,
October 1, 2009;
297(4):
H1354 - H1360.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Liu, W. Ren, R. Warburton, D. Toksoz, and B. L. Fanburg
Serotonin induces Rho/ROCK-dependent activation of Smads 1/5/8 in pulmonary artery smooth muscle cells
FASEB J,
July 1, 2009;
23(7):
2299 - 2306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Guilluy, S. Eddahibi, C. Agard, C. Guignabert, M. Izikki, L. Tu, L. Savale, M. Humbert, E. Fadel, S. Adnot, et al.
RhoA and Rho Kinase Activation in Human Pulmonary Hypertension: Role of 5-HT Signaling
Am. J. Respir. Crit. Care Med.,
June 15, 2009;
179(12):
1151 - 1158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ismail, A. Sturrock, P. Wu, B. Cahill, K. Norman, T. Huecksteadt, K. Sanders, T. Kennedy, and J. Hoidal
NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-{beta}1 and insulin-like growth factor binding protein-3
Am J Physiol Lung Cell Mol Physiol,
March 1, 2009;
296(3):
L489 - L499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Liu and B. L. Fanburg
Phospholipase D signaling in serotonin-induced mitogenesis of pulmonary artery smooth muscle cells
Am J Physiol Lung Cell Mol Physiol,
September 1, 2008;
295(3):
L471 - L478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Yang, C. Yang, A. Farberman, T. C. Rideout, C. F. M. de Lange, J. France, and M. Z. Fan
The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth
J Anim Sci,
April 1, 2008;
86(14_suppl):
E36 - E50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Carlin, A. J. Peacock, and D. J. Welsh
Fluvastatin Inhibits Hypoxic Proliferation and p38 MAPK Activity in Pulmonary Artery Fibroblasts
Am. J. Respir. Cell Mol. Biol.,
October 1, 2007;
37(4):
447 - 456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Liu, M. Li, R. R. Warburton, N. S. Hill, and B. L. Fanburg
The 5-HT transporter transactivates the PDGF{beta} receptor in pulmonary artery smooth muscle cells
FASEB J,
September 1, 2007;
21(11):
2725 - 2734.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Guilluy, M. Rolli-Derkinderen, P.-L. Tharaux, G. Melino, P. Pacaud, and G. Loirand
Transglutaminase-dependent RhoA Activation and Depletion by Serotonin in Vascular Smooth Muscle Cells
J. Biol. Chem.,
February 2, 2007;
282(5):
2918 - 2928.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Stenmark, K. A. Fagan, and M. G. Frid
Hypoxia-Induced Pulmonary Vascular Remodeling: Cellular and Molecular Mechanisms
Circ. Res.,
September 29, 2006;
99(7):
675 - 691.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Guignabert, M. Izikki, L. I. Tu, Z. Li, P. Zadigue, A.-M. Barlier-Mur, N. Hanoun, D. Rodman, M. Hamon, S. Adnot, et al.
Transgenic Mice Overexpressing the 5-Hydroxytryptamine Transporter Gene in Smooth Muscle Develop Pulmonary Hypertension
Circ. Res.,
May 26, 2006;
98(10):
1323 - 1330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Callebert, J. M. Esteve, P. Herve, K. Peoc'h, C. Tournois, L. Drouet, J. M. Launay, and L. Maroteaux
Evidence for a Control of Plasma Serotonin Levels by 5-Hydroxytryptamine2B Receptors in Mice
J. Pharmacol. Exp. Ther.,
May 1, 2006;
317(2):
724 - 731.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 American Thoracic Society.
|
|
|